Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Hysterectomy Outcomes for Benign & Malignant Indications

Obstet Gynecol; ePub 2016 Aug 5; Wallace, Fazzari, et al

There is more than a 2-fold higher complication rate with hysterectomies performed for gynecologic malignancies when compared with those performed for benign indications, according to a recent study. The study included 59,525 eligible women who underwent hysterectomy in the US for either benign (n=49,331) or malignant (n=10,194) indications from January 2008 to December 2012. Researchers found:

• All complications, including wound complications, venous thromboembolism, urinary tract infection, sepsis, blood transfusion, death, unplanned readmission, and returns to the operating room, were significantly more common for malignant hysterectomies.

• Overall rate of complications for benign cases was 7.9% vs 19.4% for malignant hysterectomy.

• Median operating time for laparoscopy in benign cases was significantly longer than for open or vaginal hysterectomy procedures.

• Median operating time in malignant cases was significantly longer than for benign cases.

Citation: Wallace SK, Fazzari MJ, Chen H, Cliby WA, Chalas E. Outcomes and postoperative complications after hysterectomies performed for benign compared with malignant indications. [Published online ahead of print August 5, 2016]. Obstet Gynecol. doi:10.1097/AOG.0000000000001591.